key: cord-1011217-2m8pqut3 authors: Marín Gabriel, Miguel A.; Cuadrado, Irene; Álvarez Fernández, Blanca; González Carrasco, Ersilia; Alonso Díaz, Clara; Llana Martín, Isabel; Sánchez, Laura; Olivas, Cristina; de las Heras, Susana; Criado, Enrique title: Multicentre Spanish study found no incidences of viral transmission in infants born to mothers with COVID‐19 date: 2020-07-28 journal: Acta Paediatr DOI: 10.1111/apa.15474 sha: 56a652695d073e0f0f2a13a8d9ba2ce4499c8978 doc_id: 1011217 cord_uid: 2m8pqut3 AIM: Our aim was to describe the clinical features of mothers infected with COVID‐19 and examine any potential vertical mother to newborn transmission. We also assessed how effective the discharge recommendations were in preventing transmission during the first month of life. METHODS: This multicentre descriptive study involved 16 Spanish hospitals. We reviewed the medical records of 42 pregnant women diagnosed with COVID‐19 from March 13, 2020, to March 29, 2020, when they were in their third trimester of pregnancy. They and their newborn infants were monitored until the infant was 1 month old. RESULTS: Over half (52.4%) of the women had a vaginal delivery. The initial clinical symptoms were coughing (66.6%) and fever (59.5%), and one mother died due to thrombo‐embolic events. We admitted 37 newborn infants to the neonatal unit (88%), and 28 were then admitted to intermediate care for organisational virus‐related reasons. No infants died, and no vertical transmission was detected during hospitalisation or follow‐up. Only six were exclusively breastfed at discharge. CONCLUSION: There was no evidence of COVID‐19 transmission in any of the infants born to COVID‐19 mothers, and the post‐discharge advice seemed effective. The measures to avoid transmission appeared to reduce exclusive breastfeeding at discharge. Due to the physiological and immunological changes that occur during gestation, pregnant women seem to be more susceptible to viral infections and could develop more obstetric complications during the COVID-19 pandemic. The main mode of viral transmission is through direct contact with respiratory droplets or indirect contact with fomites or secretions in surfaces in the immediate environment. Faecal-oral transmission is unclear, and vertical transmission has not been completely ruled out. [1] [2] [3] [4] [5] We know that the severe acute respiratory syndrome (SARS-CoV) outbreak in 2003 caused a 25% of mortality rate in pregnant women, as well as an increase in premature delivery, but there was no evidence of vertical transmission. 6, 7 There have been case reports of 11 pregnant women infected by Middle East respiratory syndrome, which was first reported in 2012. Of these, 91% had serious complications, including premature birth and perinatal or maternal death or both. Again, no vertical transmission was reported. 6 There is currently insufficient evidence about how the SARScoronavirus-2 that causes COVID-19 affects pregnant women and their newborn infants. Chen et al described nine infected pregnant women delivered by Caesarean section (C-section) and four of them had late preterm babies. They did not detect the virus in breast milk or in other maternal secretions. 3 In another series of nine pregnancies, including one set of twins, six were born preterm and one died. Again, no vertical transmission was noted. 2 Therefore, there is limited evidence to suggest that vertical viral transmission or breast milk transmission is rare, if at all present. However, it is possible to that the pandemic is leading to an increase in C-section deliveries and preterm births due to maternal indications. This may imply an increase in morbidity and mortality in these babies. We do not have precise knowledge yet on what implications our interventions have on mothers with COVID-19 and their newborn infants. Our protocols are frequently being updated during the pandemic, almost on a daily basis, and there is great disparity in how they are followed in different institutions, sometimes due to the hospitals' organisational limitations. Since March 17, 2020, the Spanish Neonatology Society has stated that mothers with few or no symptoms and asymptomatic newborn infants should be in the same room if it is possible and that contact should be managed using strict hygiene measures. This should be the case if the infection has been confirmed or the results are awaited. However, if the mother is symptomatic, the newborn infant must be admitted to the neonatal unit and separated from their mother, regardless of whether the infection has been confirmed or the results are awaited. 8 Breastfeeding could be a potential route for antibody transfer from the mother to her newborn infant. Although there is not enough evidence for firm recommendations, the current suggestion is to maintain breastfeeding, due to all of its potential benefits. [8] [9] [10] This may not always be feasible, because mothers are frequently admitted to COVID-19 patient areas of hospitals, and therefore, obtaining extracted breast milk may be difficult. This means that the newborn infants would be deprived of their mother's milk and would not be in contact with their parents if their mothers have COVID-19 symptoms or a confirmed diagnosis. The Spanish Neonatology Society has established a number of recommendations on how to proceed after discharge. These are frequent hand hygiene with soap and water for at least for 20 seconds, using a surgical or cloth mask during breastfeeding or whenever the distance between the mother and child is less than two metres and adequate breast and breast pump hygiene. Before we carried out this study, we did not know if these recommendations had been fully effective in preventing transmission during the neonatal period. Our clinical experience in handling this pandemic has been very limited. The aim of this study was to improve our knowledge of COVID-19, by describing the clinical features and the potential vertical mother to newborn transmission from mothers who tested possible for the virus. We also wanted to assess whether the post-discharge recommendations that were given were effective in preventing neonates from being infected by the virus during the first month of life. The study had two parts. First, we reviewed the initial clinical data on both the mothers and the newborn infants, and then, we described the newborn infants' follow-up during their first month of life. We reviewed the medical records of 42 pregnant women diagnosed with COVID-19 from March 13, 2020, to March 29, 2020, when they were in the third trimester of their pregnancy. They and their newborn infants were monitored throughout their hospital stay until the infants were 1 month of age. The inclusion criteria were the following: neonates born to mothers diagnosed with COVID-19, after reverse transcriptase polymerase chain reaction tests (RT-PCR) detected the virus, and informed consent. Women with negative RT-PCR results, despite compatible symptoms, were excluded from the study. The clinical information obtained from the mothers included: demographic data, disease history during the perinatal period, the number of days from the first COVID-19 symptoms to delivery, maternal treatment during gestation and specific details about the delivery. The information collected on the newborn infants included: demographic information, gestational age, birth weight, Apgar test, type of resuscitation required and any respiratory assistance needed. We also looked at any antiviral treatment, the length of the hospital stay, the age when viral tests were obtained, and their results, the infants' diagnosis at discharge and whether they received breast milk, donor milk or formula. All newborn infants were discharged to their parents, who were informed of the Spanish Neonatology Society standards for avoiding transmission. The follow-up was performed when the baby was 1 month of age. We spoke to the parents to determine whether the baby had required attention from a hospital emergency department or had been admitted to a hospital ward since discharge and for what reason. Numerical variables were expressed as means and standard deviations or medians and interquartile ranges, according to their distribution. Qualitative variables were expressed as absolute frequencies and percentages. We estimated the 95% confidence intervals and assessed normal distribution by using Kolmogorov's test. Statistical analyses were performed using Stata, version 15 software (StataCorp LLC). We included 42 women with confirmed COVID-19 in their third trimester. They were diagnosed when their babies were 37.6 ± 3.2 weeks of gestation. The most common symptoms were coughing (66.6%) and fever (59.5%) (Table 1) , with infrequent ageusia (4.7%), odynophagia (2.3%) and otalgia (2.3%). Only three patients required intensive care (7.1%), including one who died due to a massive thrombo-embolism. In most cases, the treatment received during pregnancy was hydroxychloroquine (28.5%). Azithromycin (4.7%), darunavir (2.3%) and cobicistat (2.3%) were only used in exceptional cases. No side effects from this medication were observed in the newborn infants. C-sections were performed on 20 women (47.6%), and the mothers' clinical deterioration due to COVID-19 was the indication in four patients (20.0%), who represented 9.5% of all the pregnancies. This was followed by failure to progress (20.0%), abnormal presentation (15.0%), repeated C-sections (15.0%) and presumed foetal compromise (15.0%). In three cases (15%), the reason for the C-section was not recorded. Most of the 42 neonates were term infants. Only nine were pre- There were no deaths reported during our follow-up. symptoms. These were mainly coughing, fever and dyspnoea and, less frequently, diarrhoea, headache or anosmia. The complete absence of symptoms before labour was rare and was only noted in four cases. There were three mothers who were admitted to the intensive care unit, and one mother died due to a massive thrombo-embolism. Zaigham In our study, we only had three newborn infants who initially tested positive for the virus, but then tested negative when the tests were repeated with the same samples. We interpreted these as false-positive results. Newborn infants of mothers with COVID-19 tend to have mild symptoms if they test positive for the virus. They mainly present with fever, respiratory distress, digestive intolerance, coughing and diarrhoea, 3,5,18-20 although some sepsis-like cases during the neonatal period have been reported. 21 Clinical outcomes were good in all cases, without any case of hypoxic-ischaemic encephalopathy or death during the neonatal period and minimal need for respiratory support. Our study found that most newborn infants were asymptomatic and any mild symptoms were attributable to underlying illnesses, such as prematurity, oesophagus and duodenal atresia or haemolytic disease. We had no infant deaths in our study. There is insufficient evidence about whether the virus that causes 28, 29 However, this is not always feasible, mainly due to organisational issues at hospitals. Information about how infected mothers feed their newborn infants with breast milk or formula during the immediate neonatal period is scarce. [1] [2] [3] 12 Our study found that newborn infants received formula more frequently than breast milk, both at birth and at discharge. This could have been due to various factors, such as the absence of skinto-skin contact after birth and the need to sometimes separate the mother and child. It is difficult to know what role anxiety and fear of transmission played in those decisions, both in the mother and in the healthcare providers. This aspect deserves further research. Therefore, it is essential to keep the mother and child together, when clinically possible, and promote, and guarantee, correct breastfeeding support during their hospital stay and when they are discharged. When possible, each hospital should establish certain specific areas for COVID-19 positive mothers who have none, or only mild symptoms, so they can safely stay with their newborn infants according to current recommendations. This would contribute to promoting and maintaining breastfeeding, which is important given the potential benefits it may provide in this situation. We did not detect any COVID-19 transmission during labour in the newborn infants included in our study. Therefore, the delivery method should be based on regular obstetric criteria. The measures implemented to protect the babies of infected mothers who had symptoms reduced the rates of breastfeeding at discharge. The benefits of breastfeeding have already been demonstrated, and it appears to play a role in providing immunological protection for newborn infants during the pandemic. This suggests that strategies need to be implemented to help increase the number of newborn infants that receive breast milk during their first days of life and onwards. Correct implementation of the standard hygiene recommendations given at discharge may be effective in preventing mother to child transmission during and after birth. We would like to thank the families who participated in this study and individual members of the Neo-COVID-19 Research Group: The authors have no conflicts of interest to declare. Miguel A. Marín Gabriel https://orcid.org/0000-0002-3765-4871 An analysis of 38 pregnant women with COVID-19, their newborn infants, and maternal-fetal transmission of SARS-CoV-2: maternal coronavirus infections and pregnancy outcomes Clinical analysis of 10 neonates born to mothers with 2019-nCoV pneumonia Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records Antibodies in infants born to mothers with COVID-19 pneumonia Neonatal early-onset infection with SARS-CoV-2 in 33 neonates born to mothers with COVID-19 in Wuhan, China Potential maternal and infant outcomes from Coronavirus 2019-nCoV (SARS-CoV-2) infecting pregnant women: lessons from SARS, MERS, and other human coronavirus infections Pregnancy and perinatal outcomes of women with severe acute respiratory syndrome Recomendaciones para el manejo del recién nacido en relación con la infección por SARS-Cov-2 CDC_AA_refVa l=https %3A%2F%2Fwww.cdc.gov%2Fcor onavi rus%2F201 9-ncov%2Fpre pare%2Fpre gnanc y-breas tfeed ing.html. Accessed 29 UNICEF. Coronavirus disease (COVID-19): what parents should know Manejo de la mujer embarazada y el recién nacido con COVID-19 Maternal and perinatal outcomes with COVID-19: a systematic review of 108 pregnancies Coronavirus Disease 2019 (COVID-19) pandemic and pregnancy Coronavirus Disease 2019 (COVID-19) and pregnancy: what obstetricians need to know Safe delivery for COVID-19 infected pregnancies World Health Organization. Q & A on COVID-19, pregnancy, childbirth and breastfeeding Possible vertical transmission of SARS-CoV-2 from an infected mother to her newborn Novel coronavirus infection in newborn babies under 28 days in China Vertical transmission of coronavirus disease 19 (COVID-19) from infected pregnant mothers to neonates: a review Coronavirus disease (COVID-19) and neonate: what neonatologist need to know Novel coronavirus in a 15-day-old neonate with clinical signs of sepsis, a case report Neonatal late onset infection with severe acute respiratory syndrome conoravirus 2 When separation is not the answer: breastfeeding mothers and infants affected by COVID-19 Should infants be separated from mothers with COVID-19? First, do no harm The impact of the current SARS-CoV-2 pandemic on neonatal care. Front Pediatr Interim infection prevention and control recommendations for patients with confirmed 2019 novel coronavirus (2019-nCoV) or patients under investigation for 2019-nCoV in healthcare settings Clinical management of severe acute respiratory infection when novel coronavirus (nCoV) infection is suspected. Interim guidance V 1 Safe handling of containers of expressed human milk in all settings during the SARS-CoV-2 (COVID-19) pandemic International perspectives concerning donor milk banking during the SARS-CoV-2 (COVID-19) Pandemic Expert consensus for managing pregnant women and neonates born to mothers with suspected or confirmed novel coronavirus (COVID-19) infection Multicentre Spanish study found no incidences of viral transmission in infants born to mothers with COVID-19